BeStock  
Stocks › Biotechnology › STOK

Stoke Therapeutics STOK

US equityMarket cap rank #2926Biotechnology
$25.32 −$0.30 (-1.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $25.32 0.00%
Open$25.82
Prev close$25.62
Day range$24.84 – $26.31
Volume928.4K
Market cap$1.63B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership120.7%-7.76 pts vs. prior quarter
Institutions holding240-1 vs. prior quarter
Insider trades (recent)25 buys / 25 sellsBalanced
Short interest17.28% of floatDays to cover 17.3 · as of 15 Sep 2026
Short-sale volume share15.2%5-day average of daily volume

Short-sale volume as % of daily volume

5%12%18%25%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$10.49M (5 inflow days, 15 outflow days).

The five largest holders on file together own 40.2% of shares outstanding.

Largest holders

  • BlackRock9.11%
  • RTW Investments, LP8.72%
  • FMR8.23%
  • T. Rowe Price Group, Inc.7.87%
  • Lynx1 Capital Management LP6.26%
  • Redmile Group, LLC6.12%
  • BVF Partners L.P.5.59%
  • Wellington Management Group5.45%

By investor type

  • Mutual Fund68.99%
  • Hedge Fund34.35%
  • Public Company11.62%
  • VC/PE Fund4.21%
  • Individual/Insider3.71%
  • Private Company0.78%
  • Government Pension Fund0.39%
  • Sovereign Wealth Fund0.26%

Reported short interest has fallen from 22.33% to 17.28% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 11,150,236 17.3% 17.3
31 Aug 2026 11,203,427 17.4% 11.9
14 Aug 2026 12,978,102 20.1% 12.7
31 Jul 2026 15,809,687 25.4% 27.7
15 Jul 2026 15,692,610 25.2% 20.7
30 Jun 2026 13,908,522 22.3% 10.0

Discussion

No comments yet — be the first to weigh in on STOK.

Leave a comment

Scroll to Top